December 5, 2017
December 5, 2017 —
Using a database of multiple myeloma patient samples and information, researchers at University of California San Diego School of Medicine found that high ADAR1 levels correlate with reduced survival rates. They also determined that blocking the enzyme reduces multiple myeloma regeneration in experimental models derived from patient cancer cells.
December 3, 2017
December 3, 2017 —
Two full-time University of California San Diego faculty members — Don Cleveland, who studies fundamental cellular mechanisms in the search for new treatments for diseases like amyotrophic lateral sclerosis (ALS), and James McKernan, a mathematician who investigates algebraic geometry and multivariate polynomials — are recipients of the 2018 Breakthrough Prize, along with Joanne Chory, a plant biologist at Salk Institute for Biological Studies and adjunct professor in the Division of Biological Sciences at UC San Diego.
December 1, 2017
December 1, 2017 —
The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) unanimously approved yesterday two grants worth a total of almost $8 million to University of California San Diego School of Medicine researchers investigating novel stem cell-based treatments for acute myeloid leukemia or AML.
November 30, 2017
November 30, 2017 —
Glioblastoma, the most common and aggressive form of brain cancer, typically fails to respond to treatment or rapidly becomes drug resistant. In a paper published online in the journal Cancer Cell on November 30, University of California San Diego School of Medicine researchers identified a strategy that pinpoints a genetically distinct subpopulation of patients with glioblastoma that is particularly sensitive to drugs like cilengitide that target a cell adhesion receptor known as integrin αvβ3.
November 27, 2017
November 27, 2017 —
The University of California San Diego will recognize World AIDS Day on Friday, Dec. 1 to draw attention to the impact of HIV/AIDS has on the San Diego community, the nation and the globe. In honor of the international event, which was established in 1988, the campus will sponsor a number of free activities open to the public including a display of three sections of the AIDS Memorial Quilt, the largest ongoing arts project in the world.
November 27, 2017
November 27, 2017 —
A team of University of California San Diego School of Medicine and Moores Cancer Center researchers studying new drugs designed to break resistance to cancer immunotherapy has been awarded a V Foundation for Cancer Research translational grant of $600,000 over three years.
November 20, 2017
November 20, 2017 —
The UC San Diego Health International Patient Program was recognized as the 2017 Medical Provider of the Year by the International Travel & Health Insurance Journal (ITIJ). ITIJ recognizes leading health systems from around the globe for their ability to provide comprehensive, culturally-sensitive care to patients from international destinations.
November 20, 2017
November 20, 2017 —
UC San Diego professors Michael Burkart, Catherine Constable, Richard Gallo, William Gerwick, Miroslav Krstic and Lorraine Pillus have been awarded the distinction of fellow by the American Association for the Advancement of Science (AAAS), the largest general science organization in the United States and publisher of the journal Science.
November 16, 2017
November 16, 2017 —
That “to do” list of chores and errands could actually provide a variety of health benefits, according to researchers at the University of California San Diego School of Medicine. The study, published in the Journal of the American Geriatrics Society, found women over age 65 who engaged in regular light physical activity had a reduction in the risk of mortality.
November 15, 2017
November 15, 2017 —
UC San Diego Health has expanded its treatment of rare brain tumors by launching a specialized program in the diagnosis and treatment of acoustic neuromas and complex skull base tumors. The new program will be led by Rick Friedman, MD, PhD, and Marc Schwartz, MD, internationally recognized authorities on the effective treatment of these challenging cases. Patients are currently being accepted into the program.
